Incidence of macroscopically occult Neoplasias in barrett's esophagus: Are random biopsies dispensable in the era of advanced endoscopic imaging

American Journal of Gastroenterology

Volumn 105, Issue 11, 2010, Pages 2350-2356

  Pohl, Juergen ^a   Pech, Oliver ^a   May, Andrea ^a   Manner, Hendrik ^a   Fissler Eckhoff, Annette ^a   Ell, Christian ^a  

^a DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; MIDAZOLAM; PETHIDINE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER INCIDENCE; CHROMOENDOSCOPY; DIAGNOSTIC VALUE; EARLY CANCER; ENDOSCOPY; ESOPHAGUS BIOPSY; FEMALE; HIGH RESOLUTION ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; CARCINOMA IN SITU; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY;

EID: 78149280174     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.280     Document Type: Article

References (30)

1. Wang KK , Sampliner RE. Updated guidelines 2008 for the diagnosis,surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol2008 ; 103 : 788-97.
2. Hameeteman W , Tytgat GNJ , Houthoff HJ et al. Barrett's esophagus: developmentof dysplasia and adenocarcinoma. Gastroenterol 1989 ; 96 : 1249-56.
3. Van Sandick JW , van Lanschot JJB , Kuiken BW et al. Impact of endoscopicbiopsy surveillance of Barrett's esophagus on pathological stage and clinicaloutcome of Barrett's carcinoma. Gut 1998 ; 43 : 216-22.
4. Corley DA , Levin TR , Habel LA et al. Surveillance and survival in Barrett'sadenocarcinomas: a population-based study. Gastroenterol 2002 ; 122 : 633-40.
5. Levine DS , Haggitt RC , Blount PL et al. An endoscopic biopsy protocol candiff erentiate high-grade dysplasia from early adenocarcinoma in Barrett'sesophagus. Gastroenterol 1993 ; 104 : 40-50.
6. Abrams JA , Kapel RC , Lindberg GM et al. Adherence to biopsy guidelinesfor Barrett's esophagus surveillance in the community setting in the UnitedStates. Clin Gastroenterol Hepatol 2009 ; 7 : 736-42.
7. Das D , Ishaq S , Harrison R et al. Management of Barrett's esophagus in theUK: overtreated and underbiopsied but improved by the introduction of anational randomized trial. Am J Gastroenterol 2008 ; 103 : 1079-89.
8. Falk GW , Rice TW , Goldblum JR et al. Jumbo biopsy forceps protocol stillmisses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1999 ; 49 : 170-6.
9. Edwards MJ , Gable DR , Lentsch AB et al. The rational for esophagectomyas the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996 ; 223 : 585-9.
10. Heitmiller RF , Redmond M , Hamilton SR. Barrett's esophagus with highgradedysplasia. Ann Surg 1996 ; 224 : 66-71.
11. Peters JH , Clark GW , Ireland AP et al. Outcome of adenocarcinoma arisingin Barrett's esophagus in endoscopically surveyed and nonsurveyedpatients. J Th oracic Cardiovasc Surg 1994 ; 108 : 813-21.
12. Kara MA , Peters FP , Rosmolen WD et al. High-resolution endoscopy pluschromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospectiverandomized crossover study. Endoscopy 2005 ; 37 : 929-36.
13. Pohl J , May A , Rabenstein T et al. Comparison of computed virtual chromoendoscopyand conventional chromoendoscopy with acetic acid fordetection of neoplasia in Barrett's esophagus. Endoscopy 2007 ; 39 : 594-8.
14. Hoff man A , Kiesslich R , Bender A et al. Acetic acid-guided biopsies aft ermagnifying endoscopy compared with random biopsies in the detection ofBarrett's esophagus: a prospective randomized trial with crossover design. Gastrointest Endosc 2006 ; 64 : 1-8.
15. Guelrud M , Ehrlich EE. Endoscopic classification of Barrett's esophagus. Gastrointest Endosc 2004 ; 59 : 58-65.
16. Rey JF , Inoue H , Guelrud M. Magnification endoscopy with acetic acid forBarrett's esophagus. Endoscopy 2005 ; 37 : 583-6.
17. Vazquez-Iglesias JL , Alonso-Aguirre P , Diz-Lois M et al. Acetic acid allowsEffective selection of areas for obtaining biopsy samples in Barrett's esophagus. Eur J Gastroenterol Hepatol 2007 ; 19 : 187-93.
18. Lambert R , Rey JF , Sankaranarayanan R. Magnification and chromoscopywith the acetic acid test. Endoscopy 2003 ; 35 : 437-45.
19. Pohl J , Nguyen-Tat M , Manner H et al. " Dry biopsies " by diluted epinephrinespraying optimizes biopsy mapping of long segment Barrett'sesophagus. Endoscopy 2008 ; 40 : 883-7.
20. MacDonald CE , Wicks AC , Playford RJ. Final results from 10 year cohortof patients undergoing surveillance for Barrett's esophagus: observationalstudy. Br Med J 2002 ; 321 : 1252-5.
21. Abela JE , Going JJ , Mackenzie JF et al. Systematic four-quadrant biopsydetects Barrett's dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol 2008 ; 103 : 850-5.
22. Ift ikhar SY , James PD , Steele RJC et al. Length of Barrett's esophagus: animportant factor in the development of dysplasia and adenocarcinoma. Gut 1992 ; 33 : 1155-8.
23. Reid BJ , Blount PL , Feng Z et al. Optimizing endoscopic biopsy detectionof early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol2000 ; 95 : 3089-95.
24. Egger K , Werner M , Meining A et al. Biopsy surveillance is still necessaryin patients with Barrett's oesophagus despite new endoscopic imagingtechniques. Gut 2003 ; 52 : 18-23.
25. Cameron AJ , Carpenter HA. Barrett's esophagus, high-grade dysplasia,and early adenocarcinoma: a pathological study. Am J Gastroenterol1997 ; 92 : 586-91.
26. Curvers WL , Singh R , Sing LM et al. Endoscopic tri-modal imaging for detectionof early neoplasia in Barrett's esophagus: a multi-centre feasibility studyusing high-resolution endoscopy, autofluorescence imaging and narrow bandimaging incorporated in one endoscopy system. Gut 2008 ; 57 : 167-72.
27. Dunbar KB , Okolo P , Montgomery E et al. Confocal laser endomicroscopyin Barrett's esophagus and endoscopically inapparent Barrett's neoplasia:a prospective, randomized, double-blind, controlled, crossover trial. GastrointestEndosc 2009 ; 70 : 645-54.
28. Ell C , May A , Gossner L et al. Endoscopic mucosal resection of earlycancer and high-grade dysplasia in Barrett's esophagus. Gastroenterol2000 ; 118 : 670-7.
29. Pech O , Behrens A , May A et al. Long-term results and risk factor analysisfor recurrence aft er curative endoscopic therapy in 349 patients with highgradeintraepithelial neoplasia and mucosal adenocarcinoma in Barrett'soesophagus. Gut 2008 ; 57 : 1200-6.
30. Jin Z , Cheng Y , Gu W et al. A multicenter, double-blind validation study ofmethylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res 2009 ; 69 : 4112-5.